White label – Pompe disease - ClinicalTrials.eu

Study of Pembrolizumab with Chemotherapy for Patients with HER2-Negative Inflammatory Breast Cancer

Recruiting

2 1 1 1
Investigated Drugs:
Study of Avelumab with Chemotherapy for Patients with Resectable Stomach or Gastroesophageal Junction Cancer

Recruiting

2 1 1 1
Investigated Diseases:
- Gastric cancer
- Oesophageal carcinoma
Investigated Drugs:
Study on the Effects of Dornase Alfa for Patients with Subarachnoid Hemorrhage to Improve Independence After 6 Months

Recruiting

3 1 1 1
Investigated Diseases:
- Aneurysm ruptured
Investigated Drugs:
- Dornase Alfa
Study on the Effects of Caffeine on Cognitive Function in Patients with Early to Moderate Alzheimer’s Disease

Recruiting

3 1
Investigated Drugs:
- Caffeine
Study on Atezolizumab and Bevacizumab for Patients with Intermediate-Stage Liver Cancer

Recruiting

3 1 1 1
Investigated Diseases:
- Hepatocellular carcinoma
Investigated Drugs:
- Atezolizumab
- Bevacizumab
Safety Study of Regulatory T Cells (Treg02) in Patients After Kidney Transplant

Recruiting

1 1 1 1
Investigated Diseases:
- Renal transplant
Investigated Drugs:
Study on Adding Trastuzumab and Pertuzumab to Treatment for Patients with Resectable HER2 Positive Esophageal Cancer

Recruiting

3 1 1 1
Investigated Diseases:
- Oesophageal adenocarcinoma
Investigated Drugs:
- Pertuzumab
- Trastuzumab
Study on Obinutuzumab vs. Rituximab for Children with Steroid-Dependent and Frequent Relapsing Nephrotic Syndrome

Recruiting

4 1 1 1
Investigated Diseases:
- Nephrotic syndrome
Investigated Drugs:
- Obinutuzumab
- Rituximab
Study Comparing Rituximab and KYV-101 for Patients with Active, ACPA-Positive, Treatment-Resistant Rheumatoid Arthritis

Recruiting

1 1 1 1
Investigated Diseases:
- Rheumatoid arthritis
Investigated Drugs:
- Kyv-101
- Rituximab
Study on the Safety and Effectiveness of Cabozantinib and Lanreotide for Patients with Gastroenteropancreatic and Thoracic Neuroendocrine Tumors

Recruiting

2 1 1 1
Investigated Diseases:
- Gastroenteropancreatic neuroendocrine tumour disease
Investigated Drugs:
- Lanreotide
- Cabozantinib

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies